Total Payments
$2,058
2024 Payments
$624.01
Companies
16
Transactions
49
Medicare Patients
850
Medicare Billing
$39,494
Payment Breakdown by Category
Food & Beverage$2,058 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,058 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $493.41 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $330.14 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $321.10 | 5 | $0 (2024) |
| Axsome Therapeutics, Inc. | $250.00 | 2 | $0 (2023) |
| Amgen Inc. | $173.97 | 4 | $0 (2024) |
| Lilly USA, LLC | $160.31 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $113.97 | 1 | $0 (2023) |
| Novo Nordisk Inc | $46.86 | 3 | $0 (2024) |
| Integra LifeSciences Corporation | $33.74 | 1 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $30.01 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $624.01 | 19 | AstraZeneca Pharmaceuticals LP ($195.25) |
| 2023 | $1,082 | 22 | ABBVIE INC. ($329.29) |
| 2022 | $207.19 | 5 | Amgen Inc. ($124.74) |
| 2021 | $145.19 | 3 | Janssen Pharmaceuticals, Inc ($141.89) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $89.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Obesity | ||||||
| 06/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Inflammation | ||||||
| 05/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $41.41 | General |
| Category: Respiratory | ||||||
| 05/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $33.74 | General |
| Category: Recon-Skin and Wound | ||||||
| 04/26/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Pharma Products | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 03/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: ANTIBIOTIC | ||||||
| 02/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $118.07 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Respiratory | ||||||
| 02/01/2024 | ConvaTec Inc. | AQUACEL AG+ (Device) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 01/11/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: ANTIBIOTIC | ||||||
| 12/07/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $113.97 | General |
| Category: Biological | ||||||
| 11/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Inflammation | ||||||
| 11/01/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $113.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/20/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 335 | 607 | $60,136 | $17,553 |
| 2022 | 12 | 437 | 688 | $60,379 | $18,234 |
| 2021 | 3 | 78 | 96 | $10,176 | $3,707 |
Total Patients
850
Total Services
1,391
Medicare Billing
$39,494
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 194 | $29,488 | $8,778 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 96 | $22,201 | $5,669 | 25.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 57 | 132 | $1,848 | $1,109 | 60.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 28 | 28 | $2,533 | $934.74 | 36.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 21 | 29 | $958.74 | $453.60 | 47.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 15 | $496.50 | $227.08 | 45.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 21 | $1,071 | $175.40 | 16.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 36 | 50 | $700.00 | $170.50 | 24.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 42 | $840.00 | $35.19 | 4.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 175 | $26,600 | $8,136 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 95 | $21,970 | $5,871 | 26.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 25 | 25 | $2,262 | $868.01 | 38.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 12 | 12 | $767.64 | $753.56 | 98.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 15 | $1,365 | $495.06 | 36.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 18 | 29 | $860.60 | $473.68 | 55.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 77 | 143 | $2,002 | $419.58 | 21.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $420.00 | $377.71 | 89.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 22 | 23 | $760.38 | $358.53 | 47.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 58 | 75 | $1,050 | $257.73 | 24.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 22 | $1,122 | $175.15 | 15.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 60 | $1,200 | $48.38 | 4.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 64 | $9,728 | $3,606 | 37.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 19 | 20 | $280.00 | $60.00 | 21.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 12 | $168.00 | $41.76 | 24.9% |
About Melissa Corbin
Melissa Corbin is a Nurse Practitioner healthcare provider based in Russellville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2021. The National Provider Identifier (NPI) number assigned to this provider is 1922678143.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Corbin has received a total of $2,058 in payments from pharmaceutical and medical device companies, with $624.01 received in 2024. These payments were reported across 49 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,058).
As a Medicare-enrolled provider, Corbin has provided services to 850 Medicare beneficiaries, totaling 1,391 services with total Medicare billing of $39,494. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Russellville, KY
- Active Since 06/29/2021
- Last Updated 03/11/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1922678143
Products in Payments
- VRAYLAR (Drug) $493.41
- XARELTO (Drug) $321.10
- Auvelity (Drug) $250.00
- MOUNJARO (Drug) $160.31
- BREZTRI (Drug) $153.84
- FARXIGA (Drug) $134.89
- Repatha (Biological) $124.74
- Veozah (Drug) $113.97
- Otezla (Drug) $49.23
- AIRSUPRA (Drug) $41.41
- Integra (Device) $33.74
- Wegovy (Drug) $30.97
- NUZYRA (Drug) $30.01
- VOQUEZNA (Drug) $28.00
- COLLAGENASE SANTYL (Drug) $22.22
- PREMARIN (Drug) $20.23
- REXULTI (Drug) $16.89
- Rybelsus (Drug) $15.89
- AQUACEL AG+ (Device) $13.78
- Xofluza (Drug) $3.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Russellville
Natalie Hill, Anp, ANP
Nurse Practitioner — Payments: $2,033
Nurse Practitioner $2,033
Lindsey Sharp
Nurse Practitioner — Payments: $1,413
Nurse Practitioner $1,413
Karen Branch, Np, NP
Nurse Practitioner — Payments: $1,249
Nurse Practitioner $1,249
Mrs. Bonnie Bendall, Crnp, CRNP
Nurse Practitioner — Payments: $802.15
Nurse Practitioner $802.15
Peggy Isaac, Cnp, CNP
Nurse Practitioner — Payments: $752.25
Nurse Practitioner $752.25
Jeffrey Bosold, Apn, APN
Nurse Practitioner — Payments: $638.03
Nurse Practitioner $638.03